oxycodone naloxone combination: Clinical Trials

10 trials of oxycodone naloxone combination, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

7 completed, 2 unknown, 1 terminated. 3 Phase 4, 2 Phase 3, 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 43Completed 2, Unknown 1
Phase 32Completed 1, Terminated 1
Phase 21Completed 1

Follow oxycodone naloxone combination: new trials by email Literature Review of oxycodone naloxone combination trials Research Report on oxycodone naloxone combination

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Targin® for Chronic Pain Management in Patients With Spinal Cord Injury
Oxycodone Naloxone Combination - Chronic Pain
Phase 4CompletedUniversity of British Columbia12019-09-052021-12-10
GREAT - Good Response With Appropriate Treatment
Oxycodone-Naloxone - Cancer Pain, Neoplasms
CompletedMario Negri Institute for Pharmacological Research2002014-11-012016-03-21
A Comparison of Targinact vs. Oxycodone on Gut Function After Colorectal Surgery
Targinact, Oxycodone, Laparoscopic segmental colectomy - Postoperative Pain, Postoperative Nausea and Vomiting
Phase 3CompletedUniversity of Edinburgh502014-10-012017-03-29
Opioid Induced Bowel Dysfunction in Patients Undergoing Cesarean Section
Caesarean section, Oxycodone, oxycodone-naloxone - Constipation, Pain, Postoperative
Phase 4UnknownKuopio University Hospital572012-10-012023-03-16
A Non-interventional, Observational Study for Targinact® Treatment in Patients With Chronic Severe Pain
Targinact® (oxycodone/naloxone) - Chronic Severe Pain
CompletedMundipharma CVA682012-09-012015-04-08
A Non-interventional, Observational Study for Quality of Life (Overall Health Assessment) in Patients With Chronic Severe Pain During Targinact® Treatment
Targinact® (oxycodon/naloxon) - Chronic Severe Pain
UnknownMundipharma CVA18002012-09-012013-11-13
Opioid Induced Bowel Dysfunction in Patients Undergoing Spinal Surgery
oxycodone-naloxone, Oxycodone - Constipation
Phase 4CompletedKuopio University Hospital1802012-05-012015-10-12
A Non-interventional, Observational Study for Targinact® Treatment in Patients With Severe Pain.
Targinact® (oxycodone/naloxone) - Severe Pain
CompletedMundipharma CVA13382011-04-012013-11-13
Efficacy of Oxycodone/Naloxone(OXN), Versus Oxycodone (OXY), for the Reduction of Intensity of Opioid-induced Constipation in Pain Patients
Oxycodone Naloxone, Oxycodone PR Tablets - Constipation, Pain
Phase 3TerminatedMundipharma SAS2252010-02-012015-09-28
A Study to Demonstrate the Analgesic Efficacy of Oxycodone/Naloxone Prolonged Release Tablets in Addition to Pregabalin Compared to Pregabalin Alone in Opioid-naïve Subjects Treated With Pregabalin Suffering From Moderate to Severe Pain Due to Diabetic Polyneuropathy
Oxycodone Naloxone, Placebo tablets - Moderate to Severe Pain Due to Diabetic Polyneuropathy
Phase 2CompletedMundipharma Research GmbH & Co KG982009-07-012012-08-17

Conditions studied

Chronic Pain (4)  ·  Opioid-Induced Constipation (4)  ·  Pain (4)  ·  Constipation (3)  ·  Pain, Postoperative (2)  ·  Agnosia (1)  ·  Cancer Pain (1)  ·  Neoplasms (1)  ·  Postoperative Nausea and Vomiting (1)  ·  Spinal Cord Injuries (1)

Sponsors

Mundipharma CVA (3)  ·  Kuopio University Hospital (2)  ·  Mario Negri Institute for Pharmacological Research (1)  ·  Mundipharma Research GmbH & Co KG (1)  ·  Mundipharma SAS (1)  ·  University of British Columbia (1)  ·  University of Edinburgh (1)

Countries

Belgium (3)  ·  Finland (2)  ·  Canada (1)  ·  France (1)  ·  Germany (1)  ·  Italy (1)  ·  United Kingdom (1)

Top investigators

Merja Kokki, MD, PhD (2)  ·  Andrei Krassioukov, MD,PhD,FRCPC (1)  ·  Hugh M Paterson, MD FRCS (1)

Results publications

PMID 25757607, PMID 27762434, PMID 27921252, PMID 30073471

NIH funding

2008 (1), 2009 (1)